PlanRadar, the leading digital platform for documentation, task management, and reporting in construction and real estate projects, has announced its participation at Big 5 Global 2025, taking place from 24–27 November at the Dubai World Trade Centre. The company will exhibit at Stand SS2 G110, showcasing its latest innovations designed to help construction professionals build […] The post PlanRadar Returns to Big 5 Global 2025 to Champion Data-Driven Construction in the GCC appeared first on Web-Release.

    Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.